Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanxin Technology Group is a leading healthcare service provider in China that integrates online and offline medical services with pharmacy and insurance solutions. The company operates through three core segments: out-of-hospital patient services via its Miaoshou Doctor platform and offline pharmacy network, hospital-based services that assist medical institutions in digital transformation, and innovative health insurance services through its Yuanxin Huibao brand. By connecting patients, doctors, hospitals, and pharmaceutical companies, Yuanxin focuses on comprehensive chronic disease management and specialty drug distribution. The group serves as a critical bridge in China's healthcare ecosystem, leveraging data to improve drug accessibility and patient adherence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanxin Technology.